摘要
目的探讨甲磺酸倍他司汀联合手法复位治疗良性位置性眩晕的临床效果。方法80例良性位置性眩晕患者,随机分为观察组和对照组,每组40例。对照组患者仅进行手法复位治疗,观察组患者进行甲磺酸倍他司汀联合手法复位治疗。比较两组患者的临床疗效、Berg平衡量表(BBS)评分、计时平衡试验值、前庭症状指数(VSI)评分及复发率。结果观察组患者治疗总有效率97.50%显著高于对照组的75.00%,差异具有统计学意义(P<0.05)。观察组患者BBS评分(51.28±2.88)分及计时平衡试验值(112.01±6.87)s均显著高于对照组的(29.01±1.12)分、(96.44±5.55)s,VSI评分(22.61±1.71)分显著低于对照组的(35.01±2.44)分,差异具有统计学意义(P<0.05)。观察组患者复发率7.50%显著低于对照组的30.00%,差异具有统计学意义(P<0.05)。结论对良性位置性眩晕患者进行甲磺酸倍他司汀联合手法复位治疗,其治疗效果显著,临床症状得以有效改善,平衡感得以显著提高,且复发率显著降低,值得临床大力推广使用。
Objective To discuss the clinical effect of betahistine mesylate combined with manual reduction in the treatment of benign positional vertigo.Methods A total of 80 patients with benign positional vertigo were randomly divided into observation group and control group,with 40 cases in each group.The control group was treated with manual reduction,and the observation group was treated with betahistine mesylate and manual reduction.The clinical efficacy,Berg balance scale(BBS)scores,timing balance test values,vestibular symptom index(VSI)scores and relapse rates were compared between the two groups.Results The total effective rate 97.50%in the observation group was significantly higher than 75.00%in the control group,and the difference was statistically significant(P<0.05).BBS score(51.28±2.88)points and the timing balance test value(112.01±6.87)s of the observation group were significantly higher than(29.01±1.12)points and(96.44±5.55)s of the control group,and VSI score(22.61±1.71)points was significantly lower than(35.01±2.44)points of the control group.All the difference was statistically significant(P<0.05).The recurrence rate 7.50%in the observation group was significantly lower than 30.00%in the control group,and the difference was statistically significant(P<0.05).Conclusion Combination of betahistine mesylate and manual reduction has significant therapeutic effect on patients with benign positional vertigo,and it can effectively improve the clinical symptoms,and significantly improve the sense of balance,and reduce the recurrence rate,which is worthy of clinical promotion and application.
作者
李月
LI Yue(Department of Internal Medicine-Neurology,Huludao Central Hospital,Huludao 125000,China)
出处
《中国实用医药》
2021年第27期131-133,共3页
China Practical Medicine
